Sector
PharmaceuticalsOpen
₹341.05Prev. Close
₹341.75Turnover(Lac.)
₹558.14Day's High
₹350.8Day's Low
₹340.252 Week's High
₹537.752 Week's Low
₹330.85Book Value
₹282.79Face Value
₹10Mkt Cap (₹ Cr.)
2,044.13P/E
19.98EPS
17.08Divi. Yield
1.47Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 58.71 | 58.71 | 58.71 | 58.71 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,552.62 | 1,447.84 | 1,331.56 | 1,201.72 |
Net Worth | 1,611.33 | 1,506.55 | 1,390.27 | 1,260.43 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 2,184.02 | 1,966.98 | 1,894.47 | 983.3 |
yoy growth (%) | 11.03 | 3.82 | 92.66 | 38.36 |
Raw materials | -1,570.51 | -1,102.84 | -1,065.01 | -695.28 |
As % of sales | 71.9 | 56.06 | 56.21 | 70.7 |
Employee costs | -141.3 | -115.55 | -97.2 | -56.1 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 236.77 | 571.39 | 533.24 | 31.3 |
Depreciation | -43.26 | -38.92 | -35.73 | -30.21 |
Tax paid | -57.18 | -126.83 | -171.95 | -3.6 |
Working capital | -112.32 | 268.04 | 207.28 | -4.75 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 11.03 | 3.82 | 92.66 | 38.36 |
Op profit growth | -56.69 | 3.12 | 362.95 | 21.29 |
EBIT growth | -57.54 | 4.15 | 479.37 | 29.94 |
Net profit growth | -62.73 | 23.04 | 1,204.29 | 493.14 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|
Gross Sales | 2,132.79 | 2,217.11 | 2,184.02 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 2,132.79 | 2,217.11 | 2,184.02 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 30.07 | 25.61 | 32.04 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,795.3 | 154.71 | 4,26,517.78 | 863.29 | 0.76 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,998.35 | 86.35 | 1,58,636.06 | 518 | 0.5 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,486.5 | 27.95 | 1,18,365.23 | 1,178.16 | 0.89 | 3,969.86 | 360.74 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.1 | 64.22 | 1,05,067.36 | 460 | 0.9 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,551.6 | 51.02 | 1,02,273.02 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Varinder Gupta
Non-Exec. & Independent Dir.
Sandhya Mehta
Joint Managing Director
Vikas Gupta
Chairman & Independent Directo
Rajender Mohan Malla
Non-Exec. & Independent Dir.
Harpal Singh
Company Sec. & Compli. Officer
Abhay Raj Singh
Director (Works)
Kushal Kumar Rana
Non-Exec. & Independent Dir.
SHARAD TYAGI
Executive Director
Abhiraj Gupta
Additional Director
Rajni Jha
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by IOL Chemicals & Pharmaceuticals Ltd
Summary
IOL Chemicals and Pharmaceuticals Ltd is a leading organic chemicals manufacturer and supplier in India. The company manufactures active pharmaceutical ingredient, organic chemicals and intermediates. The company was incorporated in the year 1986.The company manufactures and supplies industrial chemicals and bulk drugs for use in various pharmaceutical applications. Their portfolio includes industrial chemicals, industrial organic chemicals and bulk drugs.The company has two segments namely chemicals and pharmaceuticals. Under the chemical division, the company manufactures bulk chemicals, such as acetic acid and specialty chemicals, including ethyl acetate and acetic anhydride. Under pharmaceuticals division, the company manufactures active pharmaceutical ingredient, Ibuprofen.The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene. The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Ralli
Read More
The IOL Chemicals & Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹348.2 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IOL Chemicals & Pharmaceuticals Ltd is ₹2044.13 Cr. as of 22 Nov ‘24
The PE and PB ratios of IOL Chemicals & Pharmaceuticals Ltd is 19.98 and 1.21 as of 22 Nov ‘24
The 52-week high/low is the highest and lowest price at which a IOL Chemicals & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of IOL Chemicals & Pharmaceuticals Ltd is ₹330.85 and ₹537.7 as of 22 Nov ‘24
IOL Chemicals & Pharmaceuticals Ltd's CAGR for 5 Years at 14.02%, 3 Years at -9.25%, 1 Year at -21.83%, 6 Month at -8.09%, 3 Month at -21.81% and 1 Month at -15.99%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice